These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6543457)

  • 41. Leukaemic transformation in a case of thrombocythaemia. Case report and review of the literature.
    Quaglino D; Di Leonardo G; Stati M
    Acta Haematol; 2001; 106(3):122-5. PubMed ID: 11713378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early case of osteomyelosclerosis manifesting as radiological changes in the skeleton].
    Sadkiewicz S; Piotrowska E; Gorczyca-Wiśniewşka E
    Wiad Lek; 1982 Jul; 35(9):599-602. PubMed ID: 6889784
    [No Abstract]   [Full Text] [Related]  

  • 43. Massive bone marrow necrosis and postnecrotic myelofibrosis in a patient with primary thrombocythaemia.
    Majumdar G; Phillips JK; Pearson TC
    J Clin Pathol; 1994 Jul; 47(7):674-6. PubMed ID: 8089231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute myelofibrosis and other acute and subacute variants of myelofibrosis].
    Demidova AV
    Ter Arkh; 1981; 53(9):32-9. PubMed ID: 7302860
    [No Abstract]   [Full Text] [Related]  

  • 45. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.
    Florena AM; Tripodo C; Di Bernardo A; Iannitto E; Guarnotta C; Porcasi R; Ingrao S; Abbadessa V; Franco V
    J Clin Pathol; 2009 Apr; 62(4):331-8. PubMed ID: 19329711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is bone marrow biopsy essential for the diagnosis of essential thrombocythemia?
    Tefferi A
    Leuk Lymphoma; 2006 Sep; 47(9):1724-5. PubMed ID: 17064976
    [No Abstract]   [Full Text] [Related]  

  • 48. [Subacute myelofibrosis].
    Mrkos D
    Vnitr Lek; 1970 Nov; 16(11):1066-73. PubMed ID: 5488284
    [No Abstract]   [Full Text] [Related]  

  • 49. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis.
    Chen F; Zhang C; Wang W; Li L; Yan S; Sun J; Zhang M; Ji C; Hou M
    Leuk Res; 2008 Apr; 32(4):665-7. PubMed ID: 17854891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
    Kvasnicka HM; Thiele J
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
    Pikman Y; Levine RL
    Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera.
    Ganly P; Hanrahan V; Baker B; Romeril K
    Am J Hematol; 2007 Jan; 82(1):80-2. PubMed ID: 16924638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [An autopsy case of acute myelofibrosis (author's transl)].
    Irimajiri K; Hashimura S; Kazuta Y; Horiuchi A
    Rinsho Ketsueki; 1980 Nov; 21(11):1796-801. PubMed ID: 6937697
    [No Abstract]   [Full Text] [Related]  

  • 56. A megakaryocyte in a peripheral blood smear.
    Nakai T; Okamoto Y
    Int J Hematol; 2019 Dec; 110(6):647. PubMed ID: 31587146
    [No Abstract]   [Full Text] [Related]  

  • 57. European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment.
    Thiele J; Orazi A; Kvasnicka HM; Franco V; Boveri E; Gianelli U; Gisslinger H; Passamonti F; Tefferi A; Barbui T
    Haematologica; 2012 Mar; 97(3):e5-6; discussion e7-8. PubMed ID: 22383744
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute myelofibrosis and multiple chloromas of the mandible and skin.
    Saleh MN; Rodu B; Prchal JT; de Leon ER
    Int J Oral Maxillofac Surg; 1987 Feb; 16(1):108-11. PubMed ID: 3104488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Megakaryoblastic leukemia in an infant. Establishment of a megakaryocytic tumor cell line in athymic nude mice.
    Witte DP; Harris RE; Jenski LJ; Lampkin BC
    Cancer; 1986 Jul; 58(2):238-44. PubMed ID: 3719517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myelofibrotic transformation in essential thrombocythemia.
    Thiele J; Kvasnicka HM
    Haematologica; 2009 Mar; 94(3):431-3; author reply 433. PubMed ID: 19181785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.